Interventions for treating AIDS-associated Hodgkin' s lymphoma in treatment-naive adults

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Martí Carvajal, Arturo J ^a   Cardona, A F ^b   Rodriguez M L ^b  

^a Centro Colaborador Venezolano de la Red Iberoamericana de la Colaboración Cochrane   (Venezuela)

^b NONE

Author keywords

Adult; AIDS related *therapy ; Humans; Lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; GENE THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 44949162007     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006149.pub2     Document Type: Review

References (77)

1. Alfonso 1988 Alfonso PG, Sanudo EF, Carretero JM, Galindo RC, Altozano JG, Gomez LP, Manga GP. Hodgkin's disease in HIV-infected patients. Biomedicine & Pharmacotherapy 1988;42:321-5.
2. Costello 1998 Costello R, Heuberger L, Petit N, Olive D, Gastaut JA. Hodgkin's disease in patients infected with the human immunodeficiency virus. La Revue de Médecine Interne 1998;19:558-64.
3. Errante 1994 Errante D, Tirelli U, Gastaldi R, Milo D, Nosari AM, Rossi G, et al.Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT). Cancer 1994;73:437-44.
4. Errante 1994 B Errante D, Zagonel V, Vaccher E, Serraino D, Bernardi D, Sorio R, et al.Hodgkin's disease in patients with HIV infection and in the general population: comparison of clinicopathological features and survival. Annals of Oncology 1994;5 Suppl 2:37-40.
5. Errante 1999 Errante D, Gabarre J, Ridolfo AL, Rossi G, Nosari AM, Gisselbrecht C, et al.Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Annals of Oncology 1999;10:189-95.
6. Gabarre 2004 Gabarre J, Marcelin AG, Azar N, Choquet S, Levy V, Levy Y, et al.High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 2004;89:1100-8.
7. Hartmann 2003 Hartmann P, Rehwald U, Salzberger B, Franzen C, Sieber M, Wohrmann A, et al.BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection. Annals of Oncology 2003;14:1562-9.
8. Hartmann 2004 Hartmann P, Rehwald U, Salzberger B, Franzen C, Diehl V. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection. Expert Review of Anticancer Therapy 2004;4:401-10.
9. Hernández 1999 Hernández D. Hodgkinïs disease (HD) in patients with and without human immunodeficiency virus (HIV) infection: mopp/abv hybrid chemotherapy treatment [Enfermedad de hodgkin en pacientes con y sin la infección por el virus de inmunodeficiencia humana (VIH) tratamiento con el esquema híbrido mopp/abv]. Archivos del Hospital Vargas 1999;41:199-202.
10. Hernández 2001 Hernández D. Hodgkin's disease in patients with and without human immunodeficiency virus (HIV) infection: MOPP/ABV hybrid chemotherapy treatment [Enfermedad de hodgkin en pacientes con y sin la infección por el virus de inmunodeficiencia humana (VIH): tratamiento con el esquema híbrido MOPP/ABV]. Clínica Médica. Hospital de Clínicas Caracas 2001;6:89-92.
11. Jarrett 1992 Jarrett RF. Hodgkin's disease. Baillière's Clinical Haematology 1992; 5:57-79.
12. Levine 2000 Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, et al.Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG149). Journal of Acquired Immune Deficiency Syndromes 2000;24:444-50.
13. Levy 1995 Levy R, Colonna P, Tourani JM, Gastaut JA, Brice P, Raphael M, et al.Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. Leukemia & lymphoma 1995;16:451-6.
14. Monfardini 1991 Monfardini S, Tirelli U, Vaccher E, Foa R, Gavosto F. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). Annals of Oncology 1991;2 Suppl 2:201-5.
15. Nasti 2001 Nasti G, Angioni S, Nigra E, Ammassari A, Izzi I, Schiantarelli C, et al.Feasibility of the integration of Stanford V chemotherapy (CT) regimen with highly active antiretroviral therapy (HAART) and G-CSF in patients (PTS) with Hodgkin's disease and HIV infection (HDHIV). The 1st. IAS Conference on HIV Pathogenesis and Treatment (http://www.iasociety.org/). 2001.
16. Okechukwu 1991 Okechukwu CN, Ross J. Hodgkin's lymphoma in a pregnant patient with acquired immunodeficiency syndrome. Clinical Oncology (Royal College of Radiologists (Great Britain)) 1998;10:410-1.
17. Orem 2005 Orem J, Fu P, Ness A, Mwanda WO, Remick SC. Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease. East African Medical Journal 2005;82(9 Suppl):S144-9.
18. Rubio 1994 Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 1994;73:2400-7.
19. Spina 2000 Spina M, Gabarre J, Fasan M, Vaccher E, Tirelli U. Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection [Correspondence]. AIDS 2000;14:1457-58.
20. Spina 2002 Spina M, Gabarre J, Rossi G, Fasan M, Schiantarelli C, Nigra E, et al.Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 2002;100:1984-8.
21. Spina 2003 Spina M, Berretta M, Tirelli U. Hodgkin's disease in HIV. Hematology/oncology Clinics of North America 2003;17:843-58.
22. Tirelli 1992 Tirelli U, Errante D, Vaccher E, Repetto L, Rizzardini G, Spina M, et al.Hodgkin's disease in 92 patients with HIV infection: the Italian experience. GICAT (Italian Cooperative Group on AIDS & Tumors). Annals of Oncology 1992;3 Suppl 4:69-72.
23. Tirelli 1995 Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, et al.Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients fromthe Italian Cooperative Group on AIDS and Tumors. Journal of Clinical Oncology 1995;13:1758-67.
24. Tirelli 2005 Tirelli U, Vaccher E, Rossi G, Schiantarelli C, Fasan M, Spina M. Hodgkin's Disease and HIV Infection (HD-HIV) in Pre- and Post-HAART Era: The GICAT (Italian Cooperative Group on AIDS and Tumors) Experience in 139 Patients. Blood (ASH Annual Meeting Abstracts) 106: Abstract 1437. 2005.
25. Alderson 2000 Alderson P, Roberts I. Should journals publish systematic reviews that find no evidence to guide practice? Examples from injury research. British Medical Journal 2000;320:376-7.
26. Alderson 2003 Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers' Handbook 4.2.2 [updated November 2004]. In: The Cochrane Library, Issue 1, 2005. Chichester, UK: John Wiley, Sons. Ltd.
27. Berretta 2003 Berretta M, Cinelli R, Martellotta F, Spina M, Vaccher E, Tirelli U. Therapeutic approaches to AIDS-related malignancies. Oncogene 2003;22:6646-59.
28. Besson 2003 Besson C, Raphael M. Lymphoma genesis in the context of HIV infection [Lymphomagenèse au cours de l'infection par le VIH]. Annales de Médecine Interne (Paris) 2003;154:523-8.
29. Biggar 2006 Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006;108:3786-91.
30. Calza 2003 Calza L, Manfredi R, Colangeli V, Dentale N, Chiodo F. Hodgkin's disease in the setting of human immunodeficiency virus infection. Scandinavian journal of infectious diseases 2003;35:136-41.
31. Chalmers 2004 Chalmers I. Well informed uncertainties about the effects of treatments. How clinicians and patients respond?. British Medical Journal 2004;328:475-6.
32. Cooley 2003 Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematology/oncology clinics of North America 2003;17:889- 99.
33. Diringer 2003 Diringer MN. Evidence-based medicine: what do you do when there's no evidence?. Critical Care Medicine 2003;31:659-60.
34. Dolcetti 2001 Dolcetti R, Boiocchi M, Gloghini A, Carbone A. Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. European journal of cancer 2001;37:1276-87.
35. Doweiko 2004 Doweiko J, Dezube BJ, Pantanowitz L. Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach. Journal Clinical Oncology 2004;22:4227-8.
36. Easterbrook 1991 Easterbrook PJ, Berlin J, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867-72.
37. Ellis 2005 Ellis DW, Eaton M, Fox RM, Juneja S, Leong AS, Miliauskas J, et al.Diagnostic pathology of lymphoproliferative disorders. Pathology 2005;37:434-56.
38. Gabarre 2004 Gabarre J, Marcelin AG, Azar N, Choquet S, Levy V, Levy Y, et al.High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 2004;89:1100-8.
39. Gastaldi 2002 Gastaldi R, Martino P, Gentile G, Picardi V, De Propris MS, Pirillo MF, et al.Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor. Annals of oncology 2002;13:1158-60.
40. Gates 2002 Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology (Williston Park) 2002;16:657-65.
41. Gerard 2003 Gerard L, Galicier L, Boulanger E, Quint L, Lebrette MG, Mortier E, et al.Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS 2003;17:81-7.
42. Glaser 2003 Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, et al.Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer 2003;98:300-9.
43. Gluud 1998 Gluud C. "Negative trials" are positive! "Negative trials" are positive! "Negative trials" are positive! "Negative trials" are positive!. Journal of Hepatology 1998;28:731-3.
44. Grulich 1999 Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS 1999;13:839-43.
45. Hartmann 2003 Hartmann P, Rehwald U, Salzberger B, Franzen C, Sieber M, Wohrmann A, et al.BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection. Annals of Oncology 2003;14:1562-9.
46. Hartmann 2004 Hartmann P, Rehwald U, Salzberger B, Franzen C, Diehl V. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection. Expert Review of Anticancer Therapy 2004;4:401-10.
47. Hentrich 2005 Hentrich M, Maretta L, Bogner JR, Schürmann D, Jäger H, Reichelt D, et al.Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease. Haematologica. 2005 (Abst 0361).
48. Herida 2003 Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, et al.Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. Journal Clinical Oncology 2003;21:3447-53.
49. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60;327:557-60.
50. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
51. Hilman 2005 Hilman S, Brammer C. Human immunodeficiency virus-associated Hodgkin's disease of the anal canal. Clinical oncology (Royal College of Radiologists (Great Britain)) 2005;17:69.
52. Hoffmann 2004 Hoffmann C, Chow KU, Wolf E, Faetkenheuer G, Stellbrink HJ, van Lunzen J, et al.Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. British Journal of Haematology 2004;125:455-62.
53. ICH-GCP 1997 International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice. www.ich.org/cache/ compo/276-254-1.html.
54. ICHC 2000 International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults. Journal of the National Cancer Institute 2000;92:1823-30.
55. Ioannidis 2004 Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al.Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141:781-8.
56. Jüni 2001 Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. British Medical Journal 2001;323(7303):42-6.
57. Kang 2002 Kang EM, de Witte M, Malech H, Morgan RA, Phang S, Carter C, et al.Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood 2002;99:698-701.
58. Krishnan 2002 Krishnan A, Zaia J, Molina A. Stem cell transplantation and gene therapy for HIV-related lymphomas. Journal of hematotherapy & stem cell research 2002;11:765-75.
59. Launay 2003 Launay O, Guillevin L. Epidemiology of HIV-associated malignancies [Épidémiologie des tumeurs malignes associées à l'infection par le VIH]. Bulletin du cancer 2003;90:387- 92.
60. Levine 2000 Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, et al.Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG149). Journal of Acquired Immune Deficiency Syndromes 2000;24:444-50.
61. Lim 2005 Lim ST, Levine AM. Non-AIDS-defining cancers and HIV infection. Current HIV/AIDS reports 2005;2:146-53.
62. Lu 2005 Lu P. Staging and classification of lymphoma. Seminars in Nuclear Medicine 2005;35:160-4.
63. Lyter 1995 Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. Journal Clinical Oncology 1995;13:2540-6.
64. Massarweh 2003 Massarweh S, Udden MM, Shahab I, Kroll M, Sears DA, Lynch GR, et al.HIV-related Hodgkin's disease with central nervous system involvement and association with Epstein-Barr virus. American Journal of Hematology 2003;72:216-9.
65. Moher 2004 Moher D, Altman DG, Schulz KF, Elbourne DR. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. Canadian Medical Association Journal 2004;171:349-50.
66. Mosthaf 2006 Mosthaf FA, Hanhoff NJ, Goetzenich A, Wolf E, Knechten H. High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review [Hohe inzidenz nicht AIDS-definierender neoplasien bei HIV-infizierten patienten in Deutschland. Ein 3-jähriger bundesweiter Überblick]. Deutsche medizinische Wochenschrift 2006;131:1849-52.
67. Parekh 2003 Parekh S, Ratech H, Sparano JA. Human immunodeficiency virus-associated lymphoma. Clinical advances in hematology & oncology 2003;1:295-301.
68. Poluri 2002 Poluri A, Shah KG, Carew JF, Shaha AR, Har-El G, Lucente FE, Singh B. Hodgkin's disease of the head and neck in human immunodeficiency virus-infected patients. American journal of otolaryngology 2002;23:12-6.
69. Ponzoni 2002 Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Vigano MG, et al.Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Modern pathology 2002;15:1273-8.
70. Rapezzi 2001 Rapezzi D, Ugolini D, Ferraris AM, Racchi O, Gaetani GF. Histological subtypes of Hodgkin's disease in the setting of HIV infection. Annals of hematology 2001;80:340-4.
71. Re 2001 Re A, Casari S, Cattaneo C, Facchetti F, Cadeo G, Carosi G, et al.Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer 2001;92:2739-45.
72. Serraino 2000 Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, et al.Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000;14:553-9.
73. Spina 2002 Spina M, Gabarre J, Rossi G, Fasan M, Schiantarelli C, Nigra E, et al.Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 2002;100:1984-8.
74. Spina 2003 Spina M, Berretta M, Tirelli U. Hodgkin's disease in HIV. Hematology/oncology Clinics of North America 2003;17:843-58.
75. Thompson 2004 Thompson LD, Fisher SI, Chu WS, Nelson A, Abbondanzo SL. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases. American Journal of Clinical Pathology 2004;121:727-38.
76. Vilchez 2003 Vilchez RA, Finch CJ, Jorgensen JL, Butel JS. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era. Medicine (Baltimore) 2003;82:77-81.
77. Wood 2005 Wood C, Harrington W Jr. AIDS and associated malignancies. Cell research 2005;15:947-52.